XML 84 R29.htm IDEA: XBRL DOCUMENT v3.22.0.1
Segment Information
 12 Months Ended
Dec. 31, 2021
Segment Reporting [Abstract]  
Segment Information Segment Information
We periodically evaluate our application of accounting guidance for reportable segments and disclose information about reportable segments based on the way management organizes the enterprise for making operating decisions and assessing performance. We report our business under two segments: Global Solutions and Global Products. The Global Solutions segment includes our United States distribution businesses (Medical Distribution and Patient Direct), outsourced logistics and value-added services business. Global Products manufactures and sources medical surgical products through our production and kitting operations.
We evaluate the performance of our segments based on their operating income excluding intangible amortization and acquisition-related and exit and realignment charges that, either as a result of their nature or size, would not be expected to occur as part of our normal business operations on a regular basis.
Segment assets exclude inter-segment account balances as we believe their inclusion would be misleading and not meaningful. We believe all inter-segment sales are at prices that approximate market.
The following tables present financial information by segment:
Year ended December 31,202120202019
Net revenue:
Segment net revenue
Global Solutions$7,860,475 $7,212,011 $8,243,867 
Global Products2,655,728 1,810,331 1,433,977 
Total segment net revenue10,516,203 9,022,342 9,677,844 
Inter-segment net revenue
Global Products(730,888)(542,165)(466,905)
Total inter-segment net revenue(730,888)(542,165)(466,905)
Consolidated net revenue$9,785,315 $8,480,177 $9,210,939 
Operating income:
Global Solutions$66,634 $30,946 $83,592 
Global Products371,929 259,929 65,054 
Inter-segment eliminations3,793 (7,515)45 
Intangible amortization(39,807)(41,490)(44,009)
Acquisition-related and exit and realignment charges(34,076)(37,752)(30,050)
Other (1)
— — (1,481)
Consolidated operating income$368,473 $204,118 $73,151 
Depreciation and amortization:
Global Solutions$39,485 $41,286 $42,444 
Global Products51,136 52,050 54,302 
Discontinued operations— — 19,932 
Consolidated depreciation and amortization$90,621 $93,336 $116,678 
Capital expenditures:
Global Solutions$20,266 $20,386 $10,987 
Global Products29,424 35,780 22,289 
Discontinued operations— 3,027 18,952 
Consolidated capital expenditures$49,690 $59,193 $52,228 
(1) 2019 included interest cost and net actuarial losses related to the U.S. Retirement Plan as well as software as a service (SaaS) implementation costs associated with the upgrading of our global IT platforms in connection with the redesign of our global information system strategy.
December 31,20212020
Total assets:
Global Solutions$2,158,755 $2,117,372 
Global Products1,322,084 1,135,209 
Segment assets3,480,839 3,252,581 
Cash and cash equivalents55,712 83,058 
Consolidated total assets$3,536,551 $3,335,639 
The following tables present information by geographic area. Net revenues were attributed to geographic areas based on the locations from which we ship products or provide services.
Year ended December 31,202120202019
Net revenue:
United States$9,250,331 $8,130,411 $8,871,599 
International534,984 349,766 339,340 
Consolidated net revenue$9,785,315 $8,480,177 $9,210,939 

December 31,20212020
Long-lived assets:
United States$641,630 $627,624 
International113,363 114,122 
Consolidated long-lived assets$754,993 $741,746